Disparities in radiation therapy utilization for cancer patients in Victoria
- PMID: 35357080
- PMCID: PMC9543524
- DOI: 10.1111/1754-9485.13407
Disparities in radiation therapy utilization for cancer patients in Victoria
Abstract
Introduction: To evaluate the proportion of cancer patients who received radiation therapy (RT) within 12 months of cancer diagnosis (RTU12) and identify factors associated with RTU12.
Methods: This is a population-based cohort of individuals with incident cancer, diagnosed between 2013 and 2017 in Victoria. Data linkages were performed between the Victorian Cancer Registry and Victorian Radiotherapy Minimum Dataset. The primary outcome was the proportion of patients who had RTU12. For the three most common cancers (i.e., prostate, breast and lung cancer), the time trend in RTU12 and factors associated with RTU12 were evaluated.
Results: The overall RTU12 in our study cohort was 26-20% radical RT and 6% palliative RT. Of the 21,735 men with prostate cancer, RTU12 was 17%, with no significant change over time (P-trend = 0.53). In multivariate analyses, increasing age and lower socioeconomic status were independently associated with higher RTU12 for prostate cancer. Of the 20,883 women with breast cancer, RTU12 was 64%, which increased from 62% in 2013 to 65% in 2017 (P-trend < 0.05). In multivariate analyses, age, socioeconomic status and area of residency were independently associated with RTU12 for breast cancer. Of the 13,093 patients with lung cancer, RTU12 was 42%, with no significant change over time (P-trend = 0.16). In multivariate analyses, younger age, male and lower socioeconomic status were independently associated with higher RTU12.
Conclusion: In this large population-based state-wide cohort of cancer patients, only 1 in 4 had RT within 12 months of diagnosis. There were marked sociodemographic disparities in RTU12 for prostate, breast and lung cancer patients.
Keywords: Radiation oncology; Radiotherapy utilization; health services.
© 2022 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists.
Comment in
-
Great expectations or waiting for Godot? Time for development of a near real-time national reporting system of radiotherapy utilisation.J Med Imaging Radiat Oncol. 2022 Sep;66(6):826-829. doi: 10.1111/1754-9485.13437. Epub 2022 May 24. J Med Imaging Radiat Oncol. 2022. PMID: 35610753 No abstract available.
References
-
- Barton MB, Jacob S, Shafiq J et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014; 112: 140–4. - PubMed
-
- Barton MB, Delaney GP. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist? J Med Imaging Radiat Oncol 2011; 55: 433–41. - PubMed
-
- Gabriel G, Barton M, Delaney GP. The effect of travel distance on radiotherapy utilization in NSW and ACT. Radiother Oncol 2015; 117: 386–9. - PubMed
-
- Yap ML, O'Connell DL, Goldsbury D, Weber M, Barton M. Factors associated with radiotherapy utilisation in New South Wales, Australia: results from the 45 and up study. Clin Oncol 2020; 32: 282–91. - PubMed
-
- Vinod SK, Simonella L, Goldsbury D, Delaney GP, Armstrong B, O'Connell DL. Underutilization of radiotherapy for lung cancer in New South Wales, Australia. Cancer 2010; 116: 686–94. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
